SuperworthCo-Diagnostics shares outstanding CODX
Diluted shares outstanding, averaged over each quarter, from 2016.
- Latest quarter, to Jun 30, 2026
- 4.3M
- On a year earlier
- +290.5%
- more shares
Co-Diagnostics had 4.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 290.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 1.9M | +82% |
| FY2024 | 1M | +5% |
| FY2023 | 982.2K | −0% |
| FY2022 | 987K | −1% |
| FY2021 | 999.9K | +3% |
| FY2020 | 971K | +75% |
| FY2019 | 553.4K | +29% |
| FY2018 | 430.3K | +5% |
| FY2017 | 409.7K | +24% |
| FY2016 | 329.4K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 4.3M | +291% | |
| Q1 FY26 | 2.3M | +111% | |
| Q4 FY25 | 1.9M | +82% | |
| Q3 FY25 | 1.3M | +24% | |
| Q2 FY25 | 1.1M | +10% | |
| Q1 FY25 | 1.1M | +7% | |
| Q4 FY24 | 1M | +5% | |
| Q3 FY24 | 1M | +4% | |
| Q2 FY24 | 1M | +4% | |
| Q1 FY24 | 994.8K | +1% | |
| Q4 FY23 | 982.2K | −0% | |
| Q3 FY23 | 978.7K | −6% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Co-Diagnostics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.